Marina Labella Alvarez

19PUBLICATIONS
56CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyNanotoxicology, health and safetyAllergyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 13, 2026
New Insights Into Immunomodulatory Strategies for Drug Hypersensitivity Reactions: An EAACI Task Force Report.

|Apr 06, 2026
Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.

Francesca Mori, Marina Atanaskovic-Markovic, Annick Barbaud

|Jan 19, 2026
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Marina Labella, Rafael Nuñez, Inmaculada Doña

|Nov 12, 2025
Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres.

María Salas, Alessandro Ghilarducci, Inmaculada Doña

|Sep 11, 2025
Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper.

Aslı Gelincik, Knut Brockow, Gülfem E Çelik

|May 16, 2025
Direct Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adults.

Marina Labella, Julia Rodriguez de Guzmán, Patricia Diez-Echave

Pageof 4

Frequent Collaborators

12 joint publications

Inmaculada Doña Diaz

9 joint publications

María José Torres Jaén

8 joint publications

Cristobalina Mayorga

7 joint publications

Ruben Fernandez-Santamaria